241 - 250 of 7877 Results
Title
Year
- Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s disease2024OPENTitle: Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s diseaseJournal Name: Experimental & Molecular MedicinePublisher: Springer Science and Business Media LLCVol: 56Issue #: 4Start Page: 935End Page: 945Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s12276-024-01202-5Citation Count: 0
- Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domains2024OPENTitle: Genetic and multi‐omic risk assessment of Alzheimer's disease implicates core associated biological domainsJournal Name: Alzheimer's & Dementia: Translational Research & Clinical InterventionsPublisher: WileyVol: 10Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/trc2.12461Citation Count: 3
-
OPENTitle: Prasinezumab slows motor progression in rapidly progressing early-stage Parkinson’s diseaseJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 4Start Page: 1096End Page: 1103Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41591-024-02886-yCitation Count: 10
- RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunction2024OPENTitle: RNA sequencing of olfactory bulb in Parkinson's disease reveals gene alterations associated with olfactory dysfunctionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 196Issue #:Start Page: 106514End Page: 106514Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2024.106514Best OA location URL: https://doi.org/10.1016/j.nbd.2024.106514Citation Count: 1
- The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystonia2024OPENTitle: The integrated stress response pathway and neuromodulator signaling in the brain: lessons learned from dystoniaJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 134Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci177833Citation Count: 1
-
OPENTitle: Investigating the aspect of asymmetry in brain-first versus body-first Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00685-3Best OA location URL: https://www.nature.com/articles/s41531-024-00685-3.pdfCitation Count: 1
-
OPENTitle: Genotype–phenotype correlation in PRKN-associated Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-024-00677-3Citation Count: 7
-
OPENTitle: Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissueJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-024-46832-5Citation Count: 12
-
OPENTitle: Development and characterization of a non-human primate model of disseminated synucleinopathyJournal Name: Frontiers in NeuroanatomyPublisher: Frontiers Media SAVol: 18Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnana.2024.1355940Citation Count: 0
- Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease2024RESTRICTEDTitle: Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's diseaseJournal Name:Publisher: Cold Spring Harbor LaboratoryVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1101/2024.03.22.586364Citation Count: